NuVasive (NASDAQ: NUVA) reported Q3 EPS of $0.40, in-line with the analyst estimate of $0.40. Revenue for the quarter came in at $239.6 million versus the consensus estimate of $243.52 million.

GUIDANCE:

NuVasive sees 2016 EPS of $1.64, versus the consensus of $1.65. NuVasive sees 2016 revenue of $954 million, versus the consensus of $962.35 million and prior expectation of $962.0 million.

For earnings history and earnings-related data on NuVasive (NUVA) click here.